Cullinan Therapeutics, Inc.

CGEM Healthcare Biotechnology

In the quarter to June 2026, EPS grew 24.3% and free cash flow grew 33.7%, each against the same quarter a year earlier.

12.93 1.07 −7.64%
Market cap
$901.0M
P/E
0.0×
Fwd P/E
4.8×
Dividend yield
—
F-score
n/a
Altman Z
33.57
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
98.63 210.21 290.47 467.29 467.07 398.98 377.90
Total current assets
100.09 212.28 296.56 474.47 480.19 414.67 386.76
Property, Plant, Equpment (Net)
0.18 0.13 0.08 1.17 0.99 0.68 0.42
Long-Term Investments
— — 140.40 80.88 — 204.44 58.27
Long-term assets (Other)
0.19 2.30 0.15 0.46 0.46 0.37 0.30
Total non-current assets
0.37 2.43 140.62 86.65 3.99 207.16 61.62
Total Assets
100.46 214.71 437.19 561.12 484.18 621.82 448.37
Accounts Payable
0.93 9.68 3.17 2.66 2.49 1.68 0.84
Accrued Expenses
1.59 4.64 8.58 14.14 24.20 27.66 36.12
Current Part of Taxes to Pay
— — 0.00 4.28 — — —
Total current liabilities
2.52 14.32 11.75 22.50 28.14 30.65 37.74
Preferred Shares of Subsidiary (Mandatory, Redeemable)
137.77 276.65 — — — — —
Non-current Liabilities (Other)
0.07 0.07 0.07 — — — —
Total non-current liabilities
137.85 0.07 0.07 3.59 2.15 0.85 1.90
Total liabilities
140.37 14.39 11.81 26.09 30.29 31.50 39.64
Additional Paid In Capital
0.77 292.35 584.71 585.32 654.69 958.70 995.82
Common Stock (Net)
0.00 0.00 0.00 0.01 0.00 0.01 0.01
Retained Earnings
(41.54) (93.34) (158.91) (47.69) (200.86) (368.24) (588.12)
Shareholders Equity (Other)
0.00 0.00 — — — — —
Common Equity (Total)
(39.91) 200.31 425.37 535.03 453.90 590.33 408.73
Shareholders Equity (Total)
(39.91) 200.31 425.37 535.03 453.90 590.33 408.73
Shareholders Equity and Liabilities (Total)
100.46 214.71 437.19 561.12 484.18 621.82 448.37
Shares (Common)
— 29.83 44.29 45.80 42.90 58.51 60.24
Shares (Preferred)
— — — 0.00 0.65 0.65 0.56
Shareholders Equity (Tangible)
(39.91) 200.31 425.37 535.03 453.90 590.33 408.73
Net Debt
(98.63) (210.21) (290.47) (467.29) (467.07) (398.98) (377.90)

Fold the line items

In millions of $ except per-share values · columns are period end dates